Govt Job: For M.Pharm, MS Pharm, M.Sc for a project sponsored NIPER

The National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad, is an Institute of National Importance with the proclaimed objective of becoming a Centre of Excellence for advanced research in pharmaceutical sciences.

The NIPER-Mohali was the first institute established in the year 1998 under the aegis of the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Later, the DOP established 6 new NIPERs across the country including NIPER-Hyderabad which started functioning on 19th October 2007, from the premises of the erstwhile R&D Centre of IDPL, Balanagar, Hyderabad.

Post: Junior Research Fellow (JRF)

Applications are invited for the post of Junior Research Fellow (JRF) to work on the following project sponsored by Science and Engineering Research Board, Department of Science and Technology, Government of India (SERB-SRG) under the supervision of Dr. Amol G. Dikundwar in Solid State Characterization group at Department of Pharmaceutical Analysis, NIPER Hyderabad.

The title of the project is Co-amorphous Forms for Bioavailability Enhancement of Poorly Soluble Drugs: Design, Synthesis, Characterization, and in vivo Studies.

Essential Qualifications: M.Pharm./M.S.Pharm with Pharmaceutics/Pharmaceutical Technology/Pharmaceutical Analysis specialization or M.Sc. Chemistry/Physics with Materials Science specialization/curriculum. Candidates with sound knowledge and demonstrated experience (e.g., Masters’s project thesis) in the field of solid-state pharmaceutics are preferred.

Age not exceeding 35 years as of the last date of application.

Salary: 31,000/- per month (plus HRA as per DST norms)

How to Apply: A detailed resume including the applicant’s personal details with photographs, educational background, statement of purpose, professional reference for a recommendation, and a copy of all credentials should be submitted by email (amol.dikundwar@niperhyd.ac.in). An incomplete application will not be considered.

Last Date of Application: 29th October 2022

Date of Interview: Interviews will be held as soon as possible thereafter.

Note: Only shortlisted candidates will be intimated to appear for an interview (online or offline); no TA/DA will be paid for attending the same.

Dr. Amol G. Dikundwar
Department of Pharmaceutical Analysis,
NIPER-Hyderabad, 500037.
Email: amol.dikundwar@niperhyd.ac.in

Related Posts

Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

Pune Police arrested five people for allegedly selling 50 vials of Mephentermine Sulphate Injection illegally for bodybuilding and intoxication. The accused reportedly had no valid drug licence or medical qualifications.…

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Higher capacity utilisation, operating leverage and broad-based demand across CDMO, hospital generics and consumer healthcare are expected to support margins in FY27 Piramal Pharma expects to sustain mid-teen revenue growth…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

Pune Police Bust Illegal Bodybuilding Drug Racket, 5 Arrested; 50 Mephentermine Injections Seized In Major Crackdown

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

Piramal Pharma eyes mid-teens growth in FY27, prioritises organic expansion

13 Years after Oxytocin Order, HC Seeks Compilance Status

13 Years after Oxytocin Order, HC Seeks Compilance Status

Chemist shop sealed for selling abortion medication without prescription

Chemist shop sealed for selling abortion medication without prescription

Court Rejects Bail To Two In Multi-Crore Fake Drug Scam

Court Rejects Bail To Two In Multi-Crore Fake Drug Scam

Yashoda Medicity lifts Benchmark in Critical Care to New High

Yashoda Medicity lifts Benchmark in Critical Care to New High